SCHEMBL7937985

SCHEMBL7937985

COc1ccc2c(Oc3ccc(N)cc3)c(-c3ccc(OC)c(Cl)c3)ccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 1/20 0.41
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
CYP19A1 P11511 2/20 0.39
APP P05067 3/20 0.38
GSTP1 P09211 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PTGS2 P35354 4/20 0.38
PTGS1 P23219 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
IDO1 P14902 1/20 0.36
TDO2 P48775 1/20 0.36
CYP1A1 P04798 1/20 0.35
CYP2E1 P05181 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7928761 0.91 DHFR (0.39) DHFRCYP19A1APPGSTP1SMN1; SMN2
SCHEMBL7937022 0.90 MAPT (0.44) DHFRCYP19A1APPGSTP1SMN1; SMN2
SCHEMBL7935041 0.89 ADORA2A (0.45) ADORA2AADORA1PTGS2PTGS1CYP1A2
SCHEMBL7928746 0.86 DHFR (0.41) DHFRCYP19A1APPGSTP1SMN1; SMN2
SCHEMBL7190071 0.86 GSTP1 (0.39) DHFRGSTP1PTGS2PTGS1CYP1A2
SCHEMBL7934940 0.85 SMN1; SMN2 (0.45) APPGSTP1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL7935076 0.84 ESR1 (0.40) DHFRCYP19A1APPGSTP1SMN1; SMN2
SCHEMBL7940253 0.84 TLR9 (0.44) CYP19A1APPSMN1; SMN2PTGS2CYP1A2
SCHEMBL7937708 0.83 SMN1; SMN2 (0.45) CYP19A1APPSMN1; SMN2CYP1A2CYP3A4
SCHEMBL7940249 0.82 SMN1; SMN2 (0.52) ADORA2AADORA1CYP19A1APPGSTP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0835868-B1 2-Aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods LILLY CO ELI (US) 2001-08-29 EP disclosed
US-5929090-A NOVEL COMPOUNDS FOR TREATING ESTROGEN DEPRIVATION CAUSED BY MENOPAUSE OR OVARIECTOMY; TREATING OSTEOPOROSIS, CARDIOVASCULAR DISEASES, AND ENDOMETRIOSIS ELI LILLY AND COMPANY (US) 1999-07-27 US disclosed
EP-0835868-A1 2-Aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods ELI LILLY AND COMPANY (US) 1998-04-15 EP disclosed